Diphteria-hemophilus influenzae b-pertussis-poliomyelitis-tetanus-hepatitis b
Hexacima
Indication
Hexacima (DTaP-IPV-HB-Hib) is indicated for primary and booster vaccination of infants and toddlers from six weeks of age against diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis and invasive diseases caused by Haemophilus influenzae type b (Hib). The use of this vaccine should be in accordance with official recommendations.
In other countries
The same active substances on other registers, the same brand first.
National listings
The national registers that list this EU medicine.
Documents
The official texts, at the regulator.